Exosome miRNA Loading via MS2 Phage Capsid Protein

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods for delivering specific microRNA (miRNA) using exosomes are inefficient due to limited loading capacity and stability issues, hindering their regulatory role in cells.

Innovation Solution

A method involving the use of MS2 phage capsid protein to construct lentiviral plasmids for mesenchymal stem cells, enabling the efficient packaging and secretion of exosomes loaded with target miRNA, specifically by connecting the MS2 protein coding gene to the C1C2 domain of Lactadherin protein and binding sites for the MS2 protein with target miRNA, followed by lentivirus infection and ultracentrifugation to extract functional exosomes.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Ease of manufacture

If self-assembly ability of exosomes is used to carry miRNA molecules, then the method is simple, but the loading efficiency is limited

Engineering Contradiction:
Improvesimplicity of methodVSAvoidloading efficiency of miRNA
Core Design Contradiction:
Ease of manufactureVSProductivity

Solution Approach 1:

The patent introduces MS2 phage capsid protein as an intermediary mediator between exosomes and miRNA. The MS2 protein specifically binds to pac sites engineered into the miRNA molecules, acting as a bridge that facilitates high-efficiency loading of miRNA onto exosomes. This intermediary system overcomes the limitation of passive self-assembly while maintaining a relatively simple overall process.

Inventive Principle:
Principle #24Intermediary (Mediator)

Solution Approach 2:

The patent modifies the physical-chemical parameters of the exosome surface by incorporating MS2 protein, changing its binding characteristics from non-specific to highly specific for pac sites. This parameter change in surface properties enables selective and efficient miRNA loading, transforming the loading efficiency from limited to high levels.

Inventive Principle:
Principle #35Parameter changes

2Reliability

If liposome transfection or electrotransfection is used to overexpress miRNA in cells, then the miRNA can be delivered into cells, but the method does not utilize exosome carrier capacity efficiently

Engineering Contradiction:
Improvedelivery of miRNA into cellsVSAvoidloading efficiency of exosomes
Core Design Contradiction:
ReliabilityVSProductivity

Solution Approach 1:

The MS2-pac protein-RNA interaction system serves as a specific intermediary that enables efficient capture of miRNA by exosomes. This mediator system allows exosomes to actively load miRNA with high efficiency rather than relying on passive incorporation or separate transfection methods, thereby simultaneously achieving reliable cellular delivery and high exosome loading efficiency.

Inventive Principle:
Principle #24Intermediary (Mediator)

Solution Approach 2:

The patent creates a composite system combining exosomes, MS2 protein, and pac-modified miRNA. This composite structure integrates the carrier capacity of exosomes with the specific binding ability of MS2 protein, resulting in a hybrid delivery system that achieves both high loading efficiency and reliable cellular delivery that neither component could achieve alone.

Inventive Principle:
Principle #40Composite materials

3Reliability

If exosomes are used as miRNA carriers to deliver between cells, then the regulatory role is effective, but the efficiency of specific action is not high due to limited number of intracellular proteins and RNA carried by exosomes

Engineering Contradiction:
Improveregulatory role of miRNAVSAvoidefficiency of specific action
Core Design Contradiction:
ReliabilityVSProductivity

Solution Approach 1:

The patent applies local quality modification by engineering specific pac binding sites into the miRNA molecules and equipping exosomes with MS2 protein at their surface. This creates a localized high-affinity binding region that concentrates miRNA loading at specific sites on the exosome, thereby enhancing the efficiency of specific action while maintaining the overall regulatory function of miRNA.

Inventive Principle:
Principle #3Local quality

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This approach significantly enhances the loading efficiency of miRNA into exosomes, allowing for precise regulation of target cells, as demonstrated by increased miRNA expression and anti-inflammatory effects in diabetic wound healing models.

Implementation Method 1

connecting the site pac protein used for riveting with MS2 to the target miRNA to construct a pac-miRNA-pac (p-miRNA-p) lentiviral plasmid, both ends of which have pac sites that bind to MS2

Methodology Applied
Scientific EffectProtein-RNA binding: Adsorption

Implementation Method 2

extracting the exosomes by ultracentrifugation

Methodology Applied
Scientific EffectUltracentrifugation: Centrifugal Separation

Data Source

PatentUS11753621B2Method for constructing functional exosomes capable of efficiently loading specific miRNA
Publication Date: 2023.09.12 GENERAL HOSPITAL OF PLA
  • US11753621B2 patent drawing
  • US11753621B2 patent drawing
  • US11753621B2 patent drawing

AI summary

The invention discloses a method for constructing functional exosomes capable of efficiently loading specific miRNA. In order to enable the exosome to carry miRNA with specific regulation function more efficiently so as to play a role in targeted regulation more accurately and efficiently, MS2 phage capsid protein is utilized to edit and construct a capture element of a specific miRNA molecule, and placenta mesenchymal stem cells are reprogrammed to enable the secreted exosome to efficiently load a target miRNA molecule, so that the target miRNA molecule is delivered to tissue cells to play a role in effective regulation, and therefore a new strategy is provided for realizing specific precise treatment in the future.